ClinicalTrials.gov
ClinicalTrials.gov Menu

Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00185913
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : April 22, 2010
Sponsor:
Information provided by:
Stanford University

Brief Summary:
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.

Condition or disease
Lung Cancer

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
Study Start Date : September 2000
Actual Primary Completion Date : October 2003
Actual Study Completion Date : May 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lung Cancer
U.S. FDA Resources




Biospecimen Retention:   Samples With DNA
blood


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors
Criteria

Inclusion Criteria:- Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors

Exclusion Criteria:- Patients without non-small cell lung cancer


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00185913


Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Quynh-Thu Le Stanford University

Responsible Party: Quynh-Thu Le, Stanford University School of Medicine
ClinicalTrials.gov Identifier: NCT00185913     History of Changes
Other Study ID Numbers: LUN0006
75318
LUN0006
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: April 22, 2010
Last Verified: April 2010

Additional relevant MeSH terms:
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Hypoxia
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases
Carcinoma, Bronchogenic
Bronchial Neoplasms
Signs and Symptoms, Respiratory
Signs and Symptoms